These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16162747)

  • 1. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension.
    Sulica R; Teirstein AS; Kakarla S; Nemani N; Behnegar A; Padilla ML
    Chest; 2005 Sep; 128(3):1483-9. PubMed ID: 16162747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function.
    Maimon N; Salz L; Shershevsky Y; Matveychuk A; Guber A; Shitrit D
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):406-11. PubMed ID: 23407231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis.
    Handa T; Nagai S; Miki S; Fushimi Y; Ohta K; Mishima M; Izumi T
    Chest; 2006 May; 129(5):1246-52. PubMed ID: 16685015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment.
    Fisher KA; Serlin DM; Wilson KC; Walter RE; Berman JS; Farber HW
    Chest; 2006 Nov; 130(5):1481-8. PubMed ID: 17099027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension in sarcoidosis.
    Baughman RP; Engel PJ; Meyer CA; Barrett AB; Lower EE
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Jun; 23(2):108-16. PubMed ID: 17937106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
    Mirsaeidi M; Omar HR; Baughman R; Machado R; Sweiss N
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):317-320. PubMed ID: 28079843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-minute walk test and health status assessment in sarcoidosis.
    Baughman RP; Sparkman BK; Lower EE
    Chest; 2007 Jul; 132(1):207-13. PubMed ID: 17625083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoidosis-associated pulmonary hypertension.
    Cordova FC; D'Alonzo G
    Curr Opin Pulm Med; 2013 Sep; 19(5):531-7. PubMed ID: 23912192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors of pulmonary hypertension in sarcoidosis.
    Bourbonnais JM; Samavati L
    Eur Respir J; 2008 Aug; 32(2):296-302. PubMed ID: 18385166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis.
    Nunes H; Humbert M; Capron F; Brauner M; Sitbon O; Battesti JP; Simonneau G; Valeyre D
    Thorax; 2006 Jan; 61(1):68-74. PubMed ID: 16227329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal scoring of serial change on chest radiography in sarcoidosis.
    Zappala CJ; Desai SR; Copley SJ; Spagnolo R; Cramer D; Sen D; Alam SM; du Bois RM; Hansell DM; Wells AU
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):130-8. PubMed ID: 22117504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung disease.
    Aduen JF; Zisman DA; Mobin SI; Venegas C; Alvarez F; Biewend M; Jolles HI; Keller CA
    Mayo Clin Proc; 2007 Jan; 82(1):48-54. PubMed ID: 17285785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry.
    Shlobin OA; Kouranos V; Barnett SD; Alhamad EH; Culver DA; Barney J; Cordova FC; Carmona EM; Scholand MB; Wijsenbeek M; Ganesh S; Lower EE; Engel PJ; Wort J; Price L; Wells AU; Nathan SD; Baughman RP
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32139456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [X-ray, laboratory, and functional parallels in intrathoracic sarcoidosis].
    Vizel IY; Vizel AA; Shaimuratov RI
    Ter Arkh; 2015; 87(3):48-52. PubMed ID: 26027240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of single-breath carbon monoxide-diffusing capacity in monitoring the bleomycin-induced lung toxicity in human].
    Wang JL; Ma SQ; Zhang YJ; Han JN; Zhu YJ; Ma Y; Shen K; Li LY
    Zhonghua Nei Ke Za Zhi; 2003 Oct; 42(10):709-12. PubMed ID: 14633466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis.
    Huitema MP; Spee M; Vorselaars VM; Boerman S; Snijder RJ; van Es HW; Reesink HJ; Grutters JC; Post MC
    Eur Respir J; 2016 Feb; 47(2):673-6. PubMed ID: 26493790
    [No Abstract]   [Full Text] [Related]  

  • 17. [Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
    Liu QX; Zheng JP; Xie YQ; Guan WJ; Jiang CY; An JY; Yu XX; Liu WT; Gao Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):510-5. PubMed ID: 24262087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis.
    Judson MA; Gilbert GE; Rodgers JK; Greer CF; Schabel SI
    Respirology; 2008 Jan; 13(1):97-102. PubMed ID: 18197917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sarcoidosis. Clinical presentation and prognosis].
    González EL; Vigliano C; Cáneva J
    Medicina (B Aires); 2010; 70(6):499-502. PubMed ID: 21163735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventional therapy in sarcoidosis-associated pulmonary arterial stenosis and pulmonary hypertension.
    Liu L; Xu J; Zhang Y; Fang L; Chai Y; Niu M; Li S
    Clin Respir J; 2017 Nov; 11(6):906-914. PubMed ID: 26666961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.